INSIGHTS ON CLINICAL TRIAL PARTNERING

• CRO Uses CRIO eSource To Double Monitoring Productivity

  Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.

• The Defensiveness Trap In Vendor Selection And Management

  In clinical research, sponsor–vendor relationships are often framed as negotiations. Yet while both sides want to achieve a successful study, the process often becomes a tug-of-war.

• Four Pivotal Categories To Elevate Your Clinical Vendor Management

  For sponsors ready to improve vendor management, technology platforms with the right framework can help you tighten budget controls, improve data integrity, or foster collaborative vendor relationships.

• ICON And Medable Drive 85% eConsent Adoption In U.S. Menopause Study

  A site-focused strategy drove strong eConsent adoption in a complex women’s health study, showing how tailored training and hands-on support boost engagement and compliance.

• A Guide To Patient Reimbursements And Payments

  9/13/2024

  Delayed or inadequate payments can harm patient retention and site efficiency. Learn how sponsors can mitigate financial toxicity, streamline reimbursement, and ensure a positive experience for all involved.

• Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC

  12/6/2024

  Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.

• Benefit From Enhanced Power And Intelligence

  8/14/2025

  Find a supply automation value engine with intelligent automation and algorithms to analyze drug supply data and automatically adjust delivery quantities to each site based on data available in IRT.

• Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them

  10/21/2025

  Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.

• Top 10 Global Pharma Company Dramatically Improves Site Payments In Drive To Become Sponsor Of Choice

  10/30/2024

  See how a pharma company reduced investigator payment cycle time by 55% while decreasing their own administrative burden by 90% in this metrics-rich case study.